Copyright
©The Author(s) 2025.
World J Clin Oncol. Aug 24, 2025; 16(8): 107987
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107987
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107987
Figure 1 Survival curve (disease-free survival) in relation to tumor surgical margin.
0 indicates negative margin, and 1 indicates positive margin.
Figure 2 Histopathological and immunohistochemical features of gastric signet ring cell carcinoma.
A and B: Gastric signet ring cell carcinoma (SRCC) infiltrating the gastric muscularis mucosa (original magnification: × 200); C: SRCC present within a lymphovascular embolus (original magnification: × 400); D: Human epidermal growth factor receptor 2-stained gastric SRCC, positive score 3+, (original magnification: × 400).
Figure 3 Overall survival curves.
Stratified by sex tumor-node-metastasis stage, CA 19-9, CEA. CA 19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen.
Figure 4 The T stage of the tumor.
A and B: Gastric signet ring cell carcinoma (SRCC) infiltrating the gastric mucosa; C: SRCC of the cardia extending into the adjacent esophagus; D: SRCC involving the gastric submucosa. A, C and D original magnification: × 400, B original magnification: × 200.
- Citation: Ebrahim NAA, Othman MO, Tahoun NS, Salama RA, Arafat A, Amin NH. Deciphering prognostic markers in gastric signet ring cell carcinoma: Human epidermal growth factor receptor 2 and other key factors. World J Clin Oncol 2025; 16(8): 107987
- URL: https://www.wjgnet.com/2218-4333/full/v16/i8/107987.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i8.107987